President Biden confirmed in a statement Monday that all companies are continuing to engage in the negotiation process, despite the host of legal battles to block the program.
Novo Nordisk, the pharma company behind Wegovy, faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.
Viking Therapeutics posted results of an experimental drug that showed even better weight loss than the current market-leading drugs, a sign that the dominance of Ozempic and Mounjaro is far from assured.
Health insurer says it is working to restore operations after Change Healthcare breach, which affected U.S. pharmacies and military clinics and hospitals worldwide.